Skip to main content

Table 1 Patients baseline characteristics

From: Percutaneous treatment of abdominal aortic aneurysm and aortic valve stenosis with ‘staged’ EVAR and TAVR: a case series

Case

Age (years)

Gender

BSA, m2

BMI (kg/m2)

NYHA class

GFR (mL/min)

LVEF (%)

Comorbidity

CAD

STS-PROM (%)

Logistic Euroscore II (%)

1

77

M

1.8

30.08

II

41

55

AH, CKD, ex-smoker, dyslipidemia, Thrombocytopenia (mild)

Chronic multifactorial anemia

Right carotid stenosis 80%; left carotid stenosis 60%

Prior NSTEMI

Critical CX stenosis treated with PCI and DES implantation

CTO of RCA

1.999

4.21

2

75

M

2.0

24.69

II

26

55

AH, dyslipidemia, ex-smoker

CKD, PAD

Paroxysmal AF

Prior LAD stenting (2007)

CTO of RCA

3.62

3.36

3

64

M

2.1

30.67

II

85

36

Ex-smoker

Dyslipidemia

Obesity

Severe BPCO (Gold 4)

Prior antero-septal STEMI

Multiple coronary stenting

Prior CABG (× 4) and LV aneurysm correction (LV plication)

2.449

4.91

4

84

M

1.8

28.58

II

70

60

AH, dyslipidemia

Asymptomatic right carotid stenosis (60–65%)

Significant CX and LM stenosis treated with DES implantation

4.283

4.05

5

83

M

1.87

27.28

II

72

35

AH, ex smoker, dyslipidemia

COPD

Permanent AF (OAC)

Bilateral carotid artery stenosis (50–55%)

Significant stenosis of distal RCA

2.937

5.32

  1. AH arterial hypertension, AF atrial fibrillation, AVA aortic valve area, BSA body surface area, BMI body mass index, CABG coronary artery bypass grafting, CAD coronary artery disease, COPD chronic obstructive pulmonary disease, CTO chronic total occlusion, CKD chronic kidney disease (eGFR < 60 mL/min/1.73 m2), CVA cerebrovascular accident, CX circumflex coronary artery, DES drug eluting stent, DM diabetes mellitus, LAD left anterior descending artery, LFLG low flow low gradient, LM left main, LV left ventricle, LVEF left ventricle ejection fraction, NYHA New York Heart Association, OAC oral anticoagulant, PAD peripheral arterial disease, PCI percutaneous coronary intervention, RCA right coronary artery, STEMI ST elevation myocardial infarction, STS-PROM Society of Thoracic Surgeons-Predicted Risk of Mortality